260 results on '"BALDUZZI, Sara"'
Search Results
2. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
3. Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
4. Surgical navigation for targeted retroperitoneal lymph-node removal: a randomised, controlled, phase 3 trial
5. Immune landscape of breast tumors with low and intermediate estrogen receptor expression
6. Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial
7. Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial
8. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
9. Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
10. Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis
11. Evaluating agreement between bodies of evidence from randomized controlled trials and cohort studies in medical research: a meta-epidemiological study
12. Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy.
13. Evaluating Concordance of Bodies of Evidence from Randomized Controlled Trials, Dietary Intake, and Biomarkers of Intake in Cohort Studies: A Meta-Epidemiological Study
14. Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study
15. Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines
16. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study
17. Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial
18. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
19. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis
20. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
21. Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer
22. Outpatient parents’ views on shared-decision-making at an Italian children’s hospital
23. Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
24. Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.
25. Review for "Mayer‐Rokitansky‐Küster‐Hauser syndrome presented as recurrent urinary tract infection in childhood (case report)"
26. Abstract P2-11-12: Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts
27. Radiotherapy, atezolizumab, and bevacizumab in rectal cancers with the aim of organ preservation: The TARZAN study.
28. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer:the GELATO trial
29. netmeta: An R Package for Network Meta-Analysis Using Frequentist Methods
30. Pediatric Bilateral Vocal Cord Immobility: New Treatment With Preservation of Voice.
31. Pediatric Bilateral Vocal Cord Immobility: New Treatment With Preservation of Voice
32. Review for "Factors and strategies influencing implementation of an intravenous iron intervention for antenatal anaemia: A mixed‐methods systematic review"
33. Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinsons Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial
34. Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial
35. Review for "Severity of COVID‐19 infection in pregnancy and adverse maternal and neonatal outcomes: A retrospective study in a tertiary center"
36. PET/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
37. Neoadjuvant atezolizumab plus docetaxel/oxaliplatin/capecitabine in non-metastatic gastric and gastroesophageal junction adenocarcinoma: The PANDA trial.
38. Type of endocrine therapy and DFS in patients with early HER2+/HR+ BC: Analysis from the phase III randomized ShortHER trial.
39. Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients:A systematic review and meta-analysis
40. Additional file 1 of Evaluating agreement between bodies of evidence from randomized controlled trials and cohort studies in medical research: a meta-epidemiological study
41. “The More the Better” Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy
42. Evaluating agreement between bodies of evidence from randomised controlled trials and cohort studies in nutrition research: meta-epidemiological study
43. Cochrane review - Trastuzumab-containing regimens for metastatic breast cancer
44. Topical treatment for hemorrhoids
45. Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis
46. Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism
47. Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
48. Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
49. MOESM1 of Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
50. Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.